Androgen receptor pathway inhibitors (ARPIs) in combination with androgen deprivation therapy (ADT) represent the foundation ...
Over the past decade, subcutaneous formulations of anticancer drugs—originally administered intravenously—have been ...
Procept Biorobotics Corp. (($PRCT)) announced an update on their ongoing clinical study. Study Overview: The WATER IV Prostate Cancer study, ...
Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Phase 2 Open-label Extension ...
A new study underway at St. David’s Surgical Hospital could help men recover faster and live a better quality of life after ...
Enlarged prostate is a common non-cancerous condition that affects older men but many patients wait months for care.